Radiomics of hepatocellular carcinoma: promising roles in patient selection, prediction, and assessment of treatment response.
Radiomics refers to the process of conversion of conventional medical images into quantifiable data ("features") which can be further mined to reveal complex patterns and relationships between the voxels in the image. These high throughput features can potentially reflect the histology of biologic t...
| Publicado en: | Abdominal Radiology Vol. 46; no. 8; pp. 3674 - 3686 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Aug2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=151456953&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 151456953 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 2366004X JT14 jtl: Abdominal Radiology issn: 2366004X maglogo: N pubinfo: dt: Aug2021 vid: 46 iid: 8 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 151456953 149956580 10.1007/s00261-021-03085-w 151456953 ppf: 3674 ppct: 12 formats: fmt: @attributes: type: P tig: atl: Radiomics of hepatocellular carcinoma: promising roles in patient selection, prediction, and assessment of treatment response. aug: au: Borhani, Amir A. Catania, Roberta Velichko, Yuri S. Hectors, Stefanie Taouli, Bachir Lewis, Sara affil: Department of Radiology, Northwestern University Feinberg School of Medicine, 676 N. Saint Clair Street, Suite 800, 60611, Chicago, IL, USA sug: ab: Radiomics refers to the process of conversion of conventional medical images into quantifiable data ("features") which can be further mined to reveal complex patterns and relationships between the voxels in the image. These high throughput features can potentially reflect the histology of biologic tissues at macroscopic and microscopic levels. Several studies have investigated radiomics of hepatocellular carcinoma (HCC) before and after treatment. HCC is a heterogeneous disease with diverse phenotypical and genotypical landscape. Due to this inherent heterogeneity, HCC lesions can manifest variable aggressiveness with different response to treatment options, including the newer targeted therapies. Hence, radiomics can be used as a potential tool to enable patient selection for therapies and to predict response to treatments and outcome. Additionally, radiomics may serve as a tool for earlier and more efficient assessment of response to treatment. Radiomics, radiogenomics, and radio-immunoprofiling and their potential roles in management of patients with HCC will be discussed and critically reviewed in this article. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|